Farcast Biosciences (formerly Mitra Biotech) is a company developing technology for personalized cancer treatment. Its CANscript platform delivers individualized treatment response predictions for patient-specific cancer treatment selection, as well as drug discovery and development. The company serves hospitals and pharmaceutical companies.